RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.

NCT01188889 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to obtain sufficient funding.

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: RAD001
DRUG: Imatinib

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]